Healthcare Realty Trust (NYSE:HR) Issues FY 2026 Earnings Guidance

Healthcare Realty Trust (NYSE:HRGet Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 1.620-1.660 for the period, compared to the consensus estimate of 0.280. The company issued revenue guidance of -.

Healthcare Realty Trust Stock Performance

Healthcare Realty Trust stock traded down $0.33 on Thursday, reaching $21.48. The company’s stock had a trading volume of 4,056,788 shares, compared to its average volume of 3,536,718. The business’s fifty day moving average price is $20.54 and its 200 day moving average price is $18.93. The company has a market cap of $7.44 billion, a price-to-earnings ratio of -37.04 and a beta of 0.98. Healthcare Realty Trust has a twelve month low of $15.28 and a twelve month high of $22.04.

Healthcare Realty Trust (NYSE:HRGet Free Report) last issued its quarterly earnings results on Thursday, July 30th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.01. The business had revenue of $278.58 million for the quarter, compared to the consensus estimate of $271.60 million. Healthcare Realty Trust had a negative net margin of 17.34% and a negative return on equity of 4.29%. The firm’s quarterly revenue was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.41 EPS. Healthcare Realty Trust has set its FY 2026 guidance at 1.620-1.660 EPS. As a group, equities analysts forecast that Healthcare Realty Trust will post 1.63 earnings per share for the current year.

Analysts Set New Price Targets

HR has been the topic of several research reports. JPMorgan Chase & Co. upped their price target on Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, July 9th. Royal Bank Of Canada raised their price objective on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Thursday, May 14th. UBS Group upped their target price on shares of Healthcare Realty Trust from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. BTIG Research reaffirmed a “buy” rating and set a $22.00 price objective on shares of Healthcare Realty Trust in a research note on Friday, June 12th. Finally, Weiss Ratings lowered Healthcare Realty Trust from a “hold (c)” rating to a “sell (d+)” rating in a research note on Monday, May 4th. Four research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $21.67.

Get Our Latest Stock Report on Healthcare Realty Trust

Insiders Place Their Bets

In other news, CAO Amanda L. Callaway sold 25,767 shares of the stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $20.37, for a total transaction of $524,873.79. Following the completion of the sale, the chief accounting officer owned 109,954 shares of the company’s stock, valued at $2,239,762.98. This represents a 18.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.56% of the company’s stock.

Hedge Funds Weigh In On Healthcare Realty Trust

Hedge funds have recently made changes to their positions in the business. Corient Private Wealth LLC increased its position in shares of Healthcare Realty Trust by 7.2% in the fourth quarter. Corient Private Wealth LLC now owns 26,097 shares of the real estate investment trust’s stock valued at $442,000 after acquiring an additional 1,757 shares during the last quarter. Mercer Global Advisors Inc. ADV raised its position in Healthcare Realty Trust by 7.4% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 57,501 shares of the real estate investment trust’s stock worth $975,000 after acquiring an additional 3,937 shares in the last quarter. Vident Advisory LLC acquired a new stake in Healthcare Realty Trust in the fourth quarter valued at $176,000. XTX Topco Ltd bought a new position in shares of Healthcare Realty Trust in the 4th quarter valued at about $2,075,000. Finally, Rush Island Management LP grew its position in shares of Healthcare Realty Trust by 15.4% in the 4th quarter. Rush Island Management LP now owns 9,007,902 shares of the real estate investment trust’s stock valued at $152,684,000 after acquiring an additional 1,204,551 shares during the period.

About Healthcare Realty Trust

(Get Free Report)

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.

Read More

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.